Adherence to levothyroxine treatment among patients with hypothyroidism in Oman: a national cross-sectional study

References

• Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99(1):39–51. doi:10.1093/bmb/ldr030.
   PubMed Web of Science ®Google Scholar
• Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, et al. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923–931. doi:10.1210/jc.2013-2409.
   PubMed Web of Science ®Google Scholar
• Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526–534. doi:10.1001/archinte.160.4.526.
   PubMed Web of Science ®Google Scholar
• Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988–1994): national health and nutrition examination survey (NHANESIII). J Clin Endocrinol Metab. 2002;87(2):489–499. doi:10.1210/jcem.87.2.8182.
   PubMed Web of Science ®Google Scholar
• Unnikrishnan AG, Kalra S, Sahay RK, et al. Prevalence of hypothyroidism in adults: an epidemiological study in eight cities of India. Indian J Endocrinol Metab. 2013;17(4):647–652. doi:10.4103/2230-8210.113755.
   PubMedGoogle Scholar
• de Carvalho GA, Paz-Filho G, Mesa C, Jr, et al. Management of endocrine disease: pitfalls on the replacement therapy for primary and Central hypothyroidism in adults. Eur J Endocrinol. 2018;178(6):R231–R244. doi:10.1530/EJE-17-0947.
   PubMed Web of Science ®Google Scholar
• Hepp Z, Wyne K, Manthena SR, et al. Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysis. Curr Med Res Opin. 2018;34(9):1673–1678. doi:10.1080/03007995.2018.1486293.
   PubMed Web of Science ®Google Scholar
• Hepp Z, Lage MJ, Espaillat R, et al. The association between adherence to levothyroxine and economic and clinical outcomes in patients with hypothyroidism in the US. J Med Econ. 2018;21(9):912–919. doi:10.1080/13696998.2018.1484749.
   PubMed Web of Science ®Google Scholar
• Dobbels F, Van Damme-Lombaert R, Vanhaecke J, et al. Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant. 2005;9(3):381–390. doi:10.1111/j.1399-3046.2005.00356.x.
   PubMed Web of Science ®Google Scholar
• Viswanathan M, Golin CE, Jones CD, et al. Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness). Evid Rep Technol Assess. 2012;208(4):1–685.
   Google Scholar
• Ramadhan A, Tamilia M. Treatment-refractory hypothyroidism. CMAJ. 2012;184(2):205–209. doi:10.1503/cmaj.110994.
   PubMed Web of Science ®Google Scholar
• Briesacher BA, Andrade SE, Fouayzi H, et al. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437–443. doi:10.1592/phco.28.4.437.
   PubMed Web of Science ®Google Scholar
• Okosieme OE. Thyroid hormone replacement: current status and challenges. Expert Opin Pharmacother. 2011;12(15):2315–2328. doi:10.1517/14656566.2011.600307.
   PubMed Web of Science ®Google Scholar
• El Helou S, Hallit S, Awada S, et al. Adherence to levothyroxine among patients with hypothyroidism in Lebanon. East Mediterr Health J. 2019;25(3):149–159. doi:10.26719/emhj.18.022.
   PubMed Web of Science ®Google Scholar
• Annavarapu K, Borra HL, Chakka RS, et al. Assessment of medication adherence and risk factors for hypothyroidism in South Indian tertiary care hospital: a cross-sectional study. J Diabetes Metab Disord Control. 2019;6(3):60–79. doi:10.15406/jdmdc.2019.06.00184.
   Google Scholar
• Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670–1751. doi:10.1089/thy.2014.0028.
   PubMed Web of Science ®Google Scholar
• Eligar V, Taylor PN, Okosieme OE, et al. Thyroxine replacement: a clinical endocrinologist’s viewpoint. Ann Clin Biochem. 2016;53(Pt 4):421–433. doi:10.1177/0004563216642255.
   PubMed Web of Science ®Google Scholar
• Oman Ministry of Health. Annual health report. Department of health information and statistics, directorate general of planning and studies. Muscat: Ministry of Health; 2018.
   Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x.
   PubMed Web of Science ®Google Scholar
• Kwan YH, Weng SD, Loh DHF, et al. Measurement properties of existing patient-reported outcome measures on medication adherence: systematic review. J Med Internet Res. 2020;22(10):e19179. doi:10.2196/19179.
   PubMed Web of Science ®Google Scholar
• Wang Y, Kong MC, Ko Y. Psychometric properties of the 8-item Morisky medication adherence scale in patients taking warfarin. Thromb Haemost. 2012;108(4):789–795. doi:10.1160/TH12-05-0368.
   PubMed Web of Science ®Google Scholar
• Vezzani S, Giannetta E, Altieri B, et al. An italian survey of compliance with major guidelines for l-thyroxine of primary hypothyroidism. Endocr Pract. 2018;24(5):419–428. doi:10.4158/EP-2017-0159.
   PubMed Web of Science ®Google Scholar
• Jamous RM, Sweileh WM, Abu-Taha AS, et al. Adherence and satisfaction with oral hypoglycemic medications: a pilot study in palestine. Int J Clin Pharm. 2011;33(6):942–948. doi:10.1007/s11096-011-9561-7.
   PubMed Web of Science ®Google Scholar
• Sweileh WM, Zyoud SH, Abu Nab’a RJ, et al. Influence of patients’ disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014;14(1):94. doi:10.1186/1471-2458-14-94.
   PubMed Web of Science ®Google Scholar
• Sweileh WM, Ihbesheh MS, Jarar IS, et al. Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav. 2011;21(3):301–305. doi:10.1016/j.yebeh.2011.04.011.
   PubMed Web of Science ®Google Scholar
• Amr M, El-Mogy A, El-Masry R. Adherence in egyptian patients with schizophrenia: the role of insight, medication beliefs and spirituality. Arab J Psychiatry. 2013;24(1):60–68. doi:10.12816/0000100.
   Google Scholar
• Alhewiti A. Adherence to long-term therapies and beliefs about medications. Int J Family Med. 2014;2014:479596–479598. doi:10.1155/2014/479596.
   PubMedGoogle Scholar
• Ashur ST, Shamsuddin K, Shah SA, et al. Reliability and known-group validity of the Arabic version of the 8-item Morisky medication adherence scale among type 2 diabetes mellitus patients. East Mediterr Health J. 2015;21(10):722–728. doi:10.26719/2015.21.10.722.
   PubMed Web of Science ®Google Scholar
• Cappelli C, Castello R, Marini F, et al. Adherence to levothyroxine treatment among patients with hypothyroidism: a Northeastern Italian survey. Front Endocrinol. 2018;9:699. doi:10.3389/fendo.2018.00699.
   PubMed Web of Science ®Google Scholar
• Kumar R, Shaukat F. Adherence to levothyroxine tablet in patients with hypothyroidism. Cureus. 2019;11(5):e4624. doi:10.7759/cureus.4624.
   PubMed Web of Science ®Google Scholar
• Rolnick SJ, Pawloski PA, Hedblom BD, et al. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2):54–65. doi:10.3121/cmr.2013.1113.
   PubMedGoogle Scholar
• Manteuffel M, Williams S, Chen W, et al. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health. 2014;23(2):112–119. doi:10.1089/jwh.2012.3972.
   PubMed Web of Science ®Google Scholar
• Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–795. doi:10.7326/0003-4819-157-11-201212040-00538.
   PubMed Web of Science ®Google Scholar
• Guglielmi R, Grimaldi F, Negro R, et al. Shift from levothyroxine tablets to liquid formulation at breakfast improves quality of life of hypothyroid patients. Endocr Metab Immune Disord Drug Targets. 2018;18(3):235–240. doi:10.2174/1871530318666180125155348.
   PubMed Web of Science ®Google Scholar
• Scavone C, Sportiello L, Cimmaruta D, et al. Medication adherence and the use of new pharmaceutical formulations: the case of levothyroxine. Minerva Endocrinol. 2016;41(2):279–289.
   PubMed Web of Science ®Google Scholar
• Ibrahim KM, Schommer JC, Morisky DE, et al. The association between medication experiences and beliefs and low medication adherence in patients with chronic disease from two different societies: the USA and the sultanate of Oman. Pharmacy. 2021;9(1):31. doi:10.3390/pharmacy9010031.
   Web of Science ®Google Scholar
• Jin J, Sklar GE, Oh VMS, et al. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269–286. doi:10.2147/tcrm.s1458.
   PubMedGoogle Scholar
• Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155–159. doi:10.5001/omj.2011.38.
   PubMedGoogle Scholar
• Hepp Z, Lage MJ, Espaillat R, et al. The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database study. J Med Econ. 2021;24(1):440–446. doi:10.1080/13696998.2021.1900202.
   PubMed Web of Science ®Google Scholar
• Rosenman R, Tennekoon V, Hill LG. Measuring bias in self-reported data. Int J Behav Healthc Res. 2011;2(4):320–332. doi:10.1504/IJBHR.2011.043414.
   PubMedGoogle Scholar